Dr. Reddy's Laboratories, Inc. is recalling 89,302 vials of Azacitidine (100mg) and Bortezomib (3.5mg) injectable medications. These medications, primarily used in hospitals and clinics for cancer treatment, were found to have failed stability specifications. This means the drugs may not maintain their quality, potency, or chemical composition until their labeled expiration date. No incidents or injuries related to this issue have been reported.
If a medication fails stability testing, it may become less effective over time or undergo chemical changes that could impact a patient's treatment. This recall ensures that only products meeting strict quality standards remain in clinical use.
Quantity: 68061 vials.
Quantity: 18261 vials.
Quantity: 2,980 vials.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.